Primary Health Care Opioid Response Initiative
Frequently Asked Questions (FAQs)
Download the FAQs that address the following questions:
- Can proposals be rejected and a Zone PCN Committee not be awarded funding?
- Can an individual PCN submit a proposal independently?
- Who do I contact if I have questions during proposal planning?
- Where can we get data for the development of our health service plan?
- What are the knowledge translation activities to be delivered by the ACFP PEER team?
- When will the ACFP PEER team knowledge translation tools be available?
- What opportunities are there for the zones to collaborate with PEER on knowledge translation?
- What is required for physicians/nurse practitioners to be able to prescribe buprenorphine/naloxone (Suboxone) or Methadone?
- Can zones spend money on partnerships with community pharma?
- Can zones encourage pharmacists to bill for their services within PCN framework?
- Is OAT covered by the Alberta Health Care Insurance Plan?
- Will naloxone kits be provided under the PHC ORI for clinic use (e.g., in emergency/first aid kits?
- How can the Zone PCN Committees find our more information on the Indigenous opioid grants and engage with First Nations groups?
- When a family physician is attending training and professional development in Opioid Use Disorder, Opioid Agonist Treatment, or other areas identified in the Zone PCN ORI plans, what hourly or daily rates can they be reimbursed at?
- Where are the rural Opioid Dependency Program (ODP) locations?
- Do the data reports capture First Nations people?
- Can palliative care patients be identified on the data reports?
Download FAQs - updated March 19, 2019